BIVI - BioVie Inc
1.36
0.020 1.471%
Share volume: 30,569
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$1.34
0.02
0.01%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2024 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 11-13-2024 | 11-13-2024 | 02-11-2025 | 05-12-2025 | 08-15-2025 | 11-10-2025 | 02-06-2026 | |
| Assets | ||||||||
| Total Assets | 25.208 M | 21.238 M | 25.694 M | 24.660 M | 21.562 M | 26.820 M | 22.503 M | |
| Current Assets | 24.048 M | 20.151 M | 24.681 M | 23.722 M | 20.698 M | 26.032 M | 21.791 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 2.104 M | 179.804 K | 195.481 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 23.844 M | 20.023 M | 24.406 M | 23.152 M | 17.545 M | 24.978 M | 20.541 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 1.160 M | 1.087 M | 1.013 M | 938.674 K | 863.705 K | 788.108 K | 711.859 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 25.208 M | 21.238 M | 25.694 M | 24.660 M | 21.562 M | 26.820 M | 22.503 M | |
| Total liabilities | 9.702 M | 7.171 M | 1.772 M | 2.842 M | 2.550 M | 1.899 M | 3.238 M | |
| Total current liabilities | 9.352 M | 6.838 M | 1.457 M | 2.547 M | 2.275 M | 1.645 M | 3.006 M | |
| Accounts Payable | 3.587 M | 3.453 M | 1.383 M | 2.476 M | 2.200 M | 1.566 M | 2.923 M | |
| Other liabilities | 349.894 K | 332.730 K | 314.915 K | 295.717 K | 275.430 K | 254.373 K | 232.517 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 349.894 K | 332.730 K | 314.915 K | 295.717 K | 275.430 K | 254.373 K | 232.517 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 15.506 M | 14.067 M | 23.923 M | 21.818 M | 19.012 M | 24.921 M | 19.265 M | |
| Common stock | 349.739 M | 352.777 M | 369.789 M | 370.473 M | 371.156 M | 382.196 M | 382.610 M | |
| Retained earnings | -334.233 M | -338.710 M | -345.867 M | -348.655 M | -352.144 M | -357.275 M | -363.345 M |